ENhANCE trial protocol: A multi-centre, randomised, phase IV trial comparing the efficacy of oxycodone/naloxone prolonged release (OXN PR) versus oxycodone prolonged release (Oxy PR) tablets in patients with advanced cancer
- Resource Type
- Article
- Source
- In
Contemporary Clinical Trials Communications December 2022 30 - Subject
- Language
- ISSN
- 2451-8654